Beyang Therapeutics: Series AAI-driven drug discovery company using its ExCEED molecular design platformOct 4, 2026RoundOSBeyang TherapeuticsCompany profile and funding historySourcesprnewswire.comMore in BiotechAusperBio · Series CProFound Therapeutics · StrategicTransfyr · SeedAISeries A · AIBiotechChinaAsiaSeries A